Mr Ravi Barod

• Nephron Sparing Treatment (NEST) for Small Renal Masses: A Feasibility Cohort-embedded Randomised Controlled Trial Comparing Percutaneous Cryoablation and Robot-assisted Partial Nephrectomy.
Neves JB, Warren H, Santiapillai J, Rode N, Cullen D, Pavlou M, Walkden M, Patki P, Barod R, Mumtaz F, Aitchison M, Bandula S, Pizzo E, Ranieri V, Williams N, Wildgoose W, Gurusamy K, Emberton M, Bex A, Tran MGB. Eur Urol. 2023 Sep 6: S0302-2838(23)03012-9. doi: 10.1016/j.eururo.2023.07.012. Online ahead of print. PMID?37684178?Free article.

• Epitheloid Angiomyolipomas of the Kidney: Rare Renal Tumors Associated With Poor Prognoses.
Aquilina J, Neves JB, El-Sheikh S, Tran-Dang MA, Walkden M, Barod R, Patki P, Mumtaz F, Bex A, Tran MGB.Urology. 2023 Jun;176:102-105. doi: 10.1016/j.urology.2023.03.017. Epub 2023 Apr 6.PMID:?37030580?Free article.

• Protocol for a MULTI-centre feasibility study to assess the use of?99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study).
Warren H, Wagner T, Gorin MA, Rowe S, Holman BF, Pencharz D, El-Sheikh S, Barod R, Patki P, Mumtaz F, Bex A, Kasivisvanathan V, Moore CM, Campain N, Cartledge J, Scarsbrook A, Hassan F, O'Brien TS, Stewart GD, Mendichovszky I, Dizdarevic S, Alanbuki A, Wildgoose WH, Wah T, Vindrola-Padros C, Pizzo E, Dehbi HM, Lorgelly P, Gurusamy K, Emberton M, Tran MGB.BMJ Open. 2023 Jan 24;13(1):e067496. doi: 10.1136/bmjopen-2022-067496.PMID:?36693694?Free PMC article.

• A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer.
Beyer K, Widdershoven C, Wintner LM, Dabestani S, Marconi L, Moss C, Kinsella N, Yuan Y, Giles RH, Barod R, Van Hemelrijck M, Bex A, Zondervan P, MacLennan S.Eur Urol Open Sci. 2022 Dec 15;48:1-11. doi: 10.1016/j.euros.2022.11.014. eCollection 2023 Feb.PMID:?36578462?Free PMC article.?Review.

• Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy.
Tan WS, Koelker M, Campain N, Cole AP, Labban M, Mossanen M, Barod R, Kibel AS, Chang SL, Bex A, Trinh QD.Eur Urol Focus. 2023 Mar;9(2):333-335. doi: 10.1016/j.euf.2022.09.018. Epub 2022 Oct 12.PMID:?36241545

• Use of?99m?Tc-sestamibi SPECT/CT for indeterminate renal tumours: a pilot diagnostic accuracy study.
Warren H, Boydell AR, Reza A, Pencharz D, Holman BF, El-Sheikh S, Wildgoose WH, Barod R, Patki P, Mumtaz F, Bex A, Wagner T, Tran MGB.BJU Int. 2022 Dec;130(6):748-750. doi: 10.1111/bju.15879. Epub 2022 Sep 26.PMID:?36053273?Free PMC article.?No abstract available.

• Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis.
Clarke CS, Melnychuk M, Ramsay AIG, Vindrola-Padros C, Levermore C, Barod R, Bex A, Hines J, Mughal MM, Pritchard-Jones K, Tran M, Shackley DC, Morris S, Fulop NJ, Hunter RM.Appl Health Econ Health Policy. 2022 Nov;20(6):905-917. doi: 10.1007/s40258-022-00745-w. Epub 2022 Jul 22.PMID:?35869355?Free PMC article.

• The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study.
COVIDSurg Collaborative.Colorectal Dis. 2022 Mar 14;24(6):708-26. doi: 10.1111/codi.16117. Online ahead of print.PMID:?35286766?Free PMC article.

• Inter-organisational collaboration enabling care delivery in a specialist cancer surgery provider network: A qualitative study.
Vindrola-Padros C, Ramsay AI, Black G, Barod R, Hines J, Mughal M, Shackley D, Fulop NJ.J Health Serv Res Policy. 2022 Jul;27(3):211-221. doi: 10.1177/13558196211053954. Epub 2022 Feb 7.PMID:?35130097?Free PMC article.

• Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy.
Graafland NM, Szabados B, Tanabalan C, Kuusk T, Mumtaz F, Barod R, Nicol D, Boleti E, Powles T, Haanen JB, Bex A.Eur Urol Oncol. 2022 Jun;5(3):373-374. doi: 10.1016/j.euo.2021.11.004. Epub 2021 Dec 20.PMID:?34933813?No abstract available.

• Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
STARSurg Collaborative and COVIDSurg Collaborative.Br J Surg. 2021 Dec 1;108(12):1448-1464. doi: 10.1093/bjs/znab336.PMID:?34871379?Free PMC article.

• Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
COVIDSurg Collaborative.Lancet Oncol. 2021 Nov;22(11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5.PMID:?34624250?Free PMC article.?Clinical Trial.

• Perioperative impact of body mass index on upper urinary tract and renal robot-assisted surgery: a single high-volume centre experience.
Fernandez-Pello S, Verma N, Kuusk T, Berezowska A, Mumtaz F, Patki P, Tran M, Barod R, Bex A.J Robot Surg. 2022 Jun;16(3):611-619. doi: 10.1007/s11701-021-01285-6. Epub 2021 Jul 27.PMID:?34313951

• Factors that influence patients' views on treatment decision-making in localised kidney cancer.
Beyer K, Barod R, Nicol D, Hussain M, Van Hemelrijck M, Kinsella N.Transl Androl Urol. 2021 Jun;10(6):2824-2827. doi: 10.21037/tau-20-1317.PMID:?34295765?Free PMC article.?No abstract available.

• Reply by Authors.
Beyer K, Barod R, Fox L, Van Hemelrijck M, Kinsella N.J Urol. 2021 Oct;206(4):839. doi: 10.1097/JU.0000000000001901.03. Epub 2021 Jul 21.PMID:?34284620?No abstract available.

• The Current Evidence for Factors that Influence Treatment Decision Making in Localized Kidney Cancer: A Mixed Methods Systematic Review.
Beyer K, Barod R, Fox L, Van Hemelrijck M, Kinsella N.J Urol. 2021 Oct;206(4):827-839. doi: 10.1097/JU.0000000000001901. Epub 2021 Jun 11.PMID:?34111958

• Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes.
Martini A, Turri F, Barod R, Rocco B, Capitanio U, Briganti A, Montorsi F, Mottrie A, Challacombe B, Lagerveld BW, Bensalah K, Abaza R, Badani KK, Mehrazin R, Buscarini M, Larcher A; Junior ERUS/YAU Working Group on Robot-assisted Surgery of the European Association of Urology.Eur Urol. 2021 Dec;80(6):730-737. doi: 10.1016/j.eururo.2021.04.003. Epub 2021 Jun 2.PMID:?34088520

• Growth and renal function dynamics of renal oncocytomas in patients on active surveillance.
Neves JB, Varley R, Agnesi S, Withington J, Rodrigues FB, Warren H, Yuminaga Y, Capitanio U, Rode N, Grant L, Tran-Dang MA, El-Sheikh S, Walkden M, Cullen D, Aitchison M, Patki P, Mumtaz F, Barod R, Bex A, Tran MGB.BJU Int. 2021 Dec;128(6):722-727. doi: 10.1111/bju.15499. Epub 2021 Aug 9.PMID:?34046981

• The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal Tumours.
Satish P, Kuusk T, Campain N, Abu-Ghanem Y, Neves J, Barod R, El-Sheikh S, Mumtaz F, Patki P, Tran M, Tran-Dang MA, Grant L, Klatte T, Bex A.Eur Urol. 2021 Aug;80(2):265-267. doi: 10.1016/j.eururo.2021.05.010. Epub 2021 May 20.PMID:?34024653?Free PMC article.?No abstract available.

• Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer.
Kuusk T, Cullen D, Neves JB, Campain N, Barod R, Boleti E, El-Sheihk S, Grant L, Kelly J, Marchetti M, Mumtaz F, Patki P, Ramachandran N, Silva P, Tran-Dang MA, Walkden M, Tran MGB, Powles T, Bex A.BJU Int. 2021 Dec;128(6):752-758. doi: 10.1111/bju.15441. Epub 2021 May 25.PMID:?33964109?Free PMC article.

• Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.
Neves JB, Vanaclocha Saiz L, Abu-Ghanem Y, Marchetti M, Tran-Dang MA, El-Sheikh S, Barod R, Beisland C, Capitanio U, Cullen D, Klatte T, Ljungberg B, Mumtaz F, Patki P, Stewart GD, Dabestani S, Tran MGB, Bex A; RECUR consortium.World J Urol. 2021 Oct;39(10):3823-3831. doi: 10.1007/s00345-021-03683-9. Epub 2021 Apr 13.PMID:?33851271

• Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic.
Tan WS, Marchese M, Paciotti M, Nguyen DD, Cone EB, Mossanen M, Webster JJ, Barod R, Bex A, Kibel AS, Chang SL, Trinh QD.Minerva Urol Nephrol. 2021 Jun;73(3):404-406. doi: 10.23736/S2724-6051.20.04197-1. Epub 2021 Mar 29.PMID:?33781018?Free article.?No abstract available.

• Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic.
COVIDSurg Collaborative.Br J Surg. 2021 Jan 27;108(1):88-96. doi: 10.1093/bjs/znaa051.PMID:?33640908?Free PMC article.

• Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes.
Tan WS, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, Pal R, Fowler W, Heer R, Elajnaf M, Douglas-Moore J, Leyshon Griffiths TR, Voss J, Wilby D, Al Kadhi O, Noel J, Vasdev N, McKay A, Ahmad I, Abu-Nayla I, Lamb B, Hill GT, Narahari K, Kynaston H, Yousuf A, Kusuma VRM, Cresswell J, Cooke P, Chakravarti A, Barod R, Bex A, Kelly JD; a multicentre collaborator group.Eur Urol Open Sci. 2021 Mar;25:39-43. doi: 10.1016/j.euros.2021.01.005. Epub 2021 Jan 9.PMID:?33458711?Free PMC article.

• How does COVID-19 impact treatment decision-making for clinicians in localised kidney cancer.
Beyer K, Van Hemelrijck M, Kinsella N, Barod R.BJUI Compass. 2020 Nov 23;2(1):11-12. doi: 10.1002/bco2.57. eCollection 2021 Jan.PMID:?33363288?Free PMC article.?No abstract available.

• A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site.
Kasivisvanathan V, Lindsay J, Rakshani-Moghadam S, Elhamshary A, Kapriniotis K, Kazantzis G, Syed B, Hines J, Bex A, Ho DH, Hayward M, Bhan C, MacDonald N, Clarke S, Walker D, Bellingan G, Moore J, Rohn J, Muneer A, Roberts L, Haddad F, Kelly JD; UCLH study group collaborators.Int J Surg. 2020 Dec;84:57-65. doi: 10.1016/j.ijsu.2020.10.019. Epub 2020 Oct 24.PMID:?33122153?Free PMC article.

• Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-Méndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative.J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6.PMID:?33021869?Free PMC article.

• Delaying surgery for patients with a previous SARS-CoV-2 infection.
COVIDSurg Collaborative.Br J Surg. 2020 Nov;107(12):e601-e602. doi: 10.1002/bjs.12050. Epub 2020 Sep 25.PMID:?32974904?Free PMC article.?No abstract available.

• Robot-assisted kidney transplantation: update from the European Robotic Urology Section (ERUS) series.
Musquera M, Peri L, Ajami T, Campi R, Tugcu V, Decaestecker K, Stockle M, Fornara P, Doumerc N, Vigues F, Barod R, Desender L, Territo A, Serni S, Vignolini G, Sahin S, Zeuschner P, Banga N, Breda A, Alcaraz A.BJU Int. 2021 Feb;127(2):222-228. doi: 10.1111/bju.15199. Epub 2020 Sep 29.PMID:?32770633

• Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy.
Gulamhusein A, Silva P, Cullen D, Tran M, Mumtaz F, Patki P, Barod R, Bex A.BJU Int. 2020 Dec;126(6):739-744. doi: 10.1111/bju.15162. Epub 2020 Aug 9.PMID:?32638490

• Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.
Tran MGB, Aben KKH, Werkhoven E, Neves JB, Fowler S, Sullivan M, Stewart GD, Challacombe B, Mahrous A, Patki P, Mumtaz F, Barod R, Bex A; British Association of Urological Surgeons.BJU Int. 2020 Jan;125(1):73-81. doi: 10.1111/bju.14862. Epub 2019 Aug 18.PMID:?31293036

• Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing?NEphron?Sparing?Treatment (NEST) for small renal masses.
Neves JB, Cullen D, Grant L, Walkden M, Bandula S, Patki P, Barod R, Mumtaz F, Aitchison M, Pizzo E, Ranieri V, Williams N, Wildgoose W, Gurusamy K, Emberton M, Bex A, Tran MGB.BMJ Open. 2019 Jun 11;9(6):e030965. doi: 10.1136/bmjopen-2019-030965.PMID:?31189686?Free PMC article.

• Re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
Tran MGB, Barod R, Bex A.Eur Urol. 2019 Jun;75(6):e179-e180. doi: 10.1016/j.eururo.2019.02.030. Epub 2019 Mar 2.PMID:?30833137?No abstract available.

• Reply to Maxine G. Tran, Ravi?Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
Macklin PS, Sullivan ME, Tapping CR, Webster GM, Roberts ISD, Verrill CL, Browning L.Eur Urol. 2019 Jun;75(6):e177-e178. doi: 10.1016/j.eururo.2019.02.029. Epub 2019 Mar 1.PMID:?30827695?No abstract available.

• Comprehensive training in robotic surgery.
Brook NR, Dell'Oglio P, Barod R, Collins J, Mottrie A.Curr Opin Urol. 2019 Jan;29(1):1-9. doi: 10.1097/MOU.0000000000000566.PMID:?30394945?Review.

• Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
Jamal M, Taneja K, Arora S, Barod R, Rogers CG, Sanchez J, Gupta NS, Williamson SR.Int J Surg Pathol. 2018 Sep;26(6):536-541. doi: 10.1177/1066896918763948. Epub 2018 Mar 21.PMID:?29560759

• Contemporary surgical management of renal oncocytoma: a nation's outcome.
Neves JB, Withington J, Fowler S, Patki P, Barod R, Mumtaz F, O'Brien T, Aitchison M, Bex A, Tran MGB; British Association of Urological Surgeons (BAUS).BJU Int. 2018 Jun;121(6):893-899. doi: 10.1111/bju.14159. Epub 2018 Mar 2.PMID:?29397002

• Initial robotic assistance in the surgical management of renal cell carcinoma with level 4 cavoatrial thrombus.
Palma-Zamora I, Dalela D, Barod R, Hsu L, Menon M, Rogers CG.J Robot Surg. 2018 Dec;12(4):737-740. doi: 10.1007/s11701-017-0766-1. Epub 2017 Dec 4.PMID:?29204888
• Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Favazza L, Chitale DA, Barod R, Rogers CG, Kalyana-Sundaram S, Palanisamy N, Gupta NS, Williamson SR.Mod Pathol. 2017 Nov;30(11):1603-1612. doi: 10.1038/modpathol.2017.72. Epub 2017 Jul 21.PMID:?28731045?Free article.

• Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.
Withington J, Neves JB, Barod R.Curr Urol Rep. 2017 Aug;18(8):61. doi: 10.1007/s11934-017-0705-8.PMID:?28664237?Review.

• Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.
Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS.Hum Pathol. 2017 May;63:149-156. doi: 10.1016/j.humpath.2017.03.004. Epub 2017 Mar 14.PMID:?28315424?Free article.

• Use of Main Renal Artery Clamping Predominates Over Minimal Clamping Techniques During Robotic Partial Nephrectomy for Complex Tumors.
Lieberman L, Barod R, Dalela D, Diaz-Insua M, Abaza R, Adshead J, Ahlawat R, Challacombe B, Dasgupta P, Gandaglia G, Moon DA, Novara G, Porpiglia F, Mottrie A, Bhandari M, Rogers C.J Endourol. 2017 Feb;31(2):149-152. doi: 10.1089/end.2016.0678. Epub 2017 Jan 11.PMID:?27936928

• Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery.
Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C.BJU Int. 2016 Aug;118(2):298-301. doi: 10.1111/bju.13408. Epub 2016 Feb 15.PMID:?27417163

• Use of the Satinsky clamp for hilar clamping during robotic partial nephrectomy: indications, technique, and multi-center outcomes.
Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Kaouk J, Allaf M, Bhayani S, Stifelman M, Rogers C.J Robot Surg. 2017 Mar;11(1):47-51. doi: 10.1007/s11701-016-0611-y. Epub 2016 Jun 21.PMID:?27329237

• Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology.
Lieberman L, Barod R, Tapper A, Kumar R, Rogers C.J Robot Surg. 2016 Sep;10(3):261-5. doi: 10.1007/s11701-016-0596-6. Epub 2016 May 4.PMID:?27146858


• Re: Craig Rogers, Ravi?Barod, Scott Schwartz, Mani Menon. Endovascular Extraction of Caval Tumor Thrombus to Facilitate Minimally Invasive Cytoreductive Nephrectomy for Metastatic Kidney Cancer. Eur Urol 2015;68:167-8.
Greco M, Butticè S, Magno C, Onida S.Eur Urol. 2016 Aug;70(2):e51-2. doi: 10.1016/j.eururo.2016.01.023. Epub 2016 Feb 2.PMID:?26850971?No abstract available.

• Robotic partial nephrectomy for renal tumours in obese patients: Perioperative outcomes in a multi-institutional analysis.
Abdullah N, Dalela D, Barod R, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C.Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E859-62. doi: 10.5489/cuaj.3197. Epub 2015 Dec 14.PMID:?26788235?Free PMC article.

• Robot-assisted hepatic mobilization and control of suprahepatic infradiaphragmatic inferior vena cava for level 3 vena caval thrombectomy: An IDEAL stage 0 study.
Sood A, Jeong W, Barod R, Bahnson E, Kirura P, Abdollah F, Bhandari M, Bahnson R, Menon M.J Surg Oncol. 2015 Dec;112(7):741-5. doi: 10.1002/jso.23980. Epub 2015 Aug 11.PMID:?26265131?Review.
• Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1 791 patients.
Potretzke AM, Knight BA, Zargar H, Kaouk JH, Barod R, Rogers CG, Mass A, Stifelman MD, Johnson MH, Allaf ME, Sherburne Figenshau R, Bhayani SB.BJU Int. 2016 Jan;117(1):131-7. doi: 10.1111/bju.13249. Epub 2015 Sep 6.PMID:?26235802

• Re: Craig Rogers, Ravi?Barod, Scott Schwartz, Mani Menon. Endovascular extraction of caval tumor thrombus to facilitate minimally invasive cytoreductive nephrectomy for metastatic kidney cancer. Eur Urol 2015;68:167-8.
Sharma P, Sawar A, Spiess P.Eur Urol. 2015 Oct;68(4):e79-80. doi: 10.1016/j.eururo.2015.05.013. Epub 2015 May 23.PMID:?26007640?No abstract available.

• Reply to Pranav Sharma, Asad Sawar and Philippe Spiess' letter to the editor re: re: Craig Rogers, Ravi?Barod, Scott Schwartz, Mani Menon. Endovascular extraction of caval tumor thrombus to facilitate minimally invasive cytoreductive nephrectomy for metastatic kidney cancer. Eur Urol 2015;68:167-8.
Rogers CG, Barod R, Schwartz S, Menon M.Eur Urol. 2015 Oct;68(4):e81. doi: 10.1016/j.eururo.2015.05.014. Epub 2015 May 21.PMID:?26004799?No abstract available.

• Endovascular Extraction of Caval Tumor Thrombus to Facilitate Minimally Invasive Cytoreductive Nephrectomy for Metastatic Kidney Cancer.
Rogers C, Barod R, Schwartz S, Menon M.Eur Urol. 2015 Jul;68(1):167-8. doi: 10.1016/j.eururo.2015.03.039. Epub 2015 Apr 3.PMID:?25843640?No abstract available.

• Primary prevention and vaccination for penile cancer.
Shabbir M, Barod R, Hegarty PK, Minhas S.Ther Adv Urol. 2013 Jun;5(3):161-9. doi: 10.1177/1756287212465456.PMID:?23730331?Free PMC article.

• Epigenetic regulation of HIF-1? in renal cancer cells involves HIF-1?/2? binding to a reverse hypoxia-response element.
Xu J, Wang B, Xu Y, Sun L, Tian W, Shukla D, Barod R, Grillari J, Grillari-Voglauer R, Maxwell PH, Esteban MA.Oncogene. 2012 Feb 23;31(8):1065-72. doi: 10.1038/onc.2011.305. Epub 2011 Aug 15.PMID:?21841824

• Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1?-mediated apoptosis.
Khan MN, Bhattacharyya T, Andrikopoulos P, Esteban MA, Barod R, Connor T, Ashcroft M, Maxwell PH, Kiriakidis S.Br J Cancer. 2011 Mar 29;104(7):1151-9. doi: 10.1038/bjc.2011.73. Epub 2011 Mar 8.PMID:?21386837?Free PMC article.

• A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib.
Tuthill M, Barod R, Pyle L, Cook T, Chew S, Gore M, Maxwell P, Eisen T.BMJ Case Rep. 2009;2009:bcr08.2008.0732. doi: 10.1136/bcr.08.2008.0732. Epub 2009 Feb 16.PMID:?21686655?Free PMC article.

• Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin.
Harten SK, Shukla D, Barod R, Hergovich A, Balda MS, Matter K, Esteban MA, Maxwell PH.Mol Biol Cell. 2009 Feb;20(3):1089-101. doi: 10.1091/mbc.e08-06-0566. Epub 2008 Dec 10.PMID:?19073886?Free PMC article.

• Initial robotic assistance in the surgical management of renal cell carcinoma with level 4 cavoatrial thrombus. Palma-Zamora I, Dalela D, Barod R, Hsu L, Menon M, Rogers CG. J Robot Surg. 2017 Dec 4. PMID: 29204888
• Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database. Favazza L, Chitale DA, Barod R, Rogers CG, Kalyana-Sundaram S, Palanisamy N, Gupta NS, Williamson SR. Mod Pathol. 2017 Nov;30(11):1603-1612. PMID: 28731045
• Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass. Withington J, Neves JB, Barod R. Curr Urol Rep. 2017 Aug;18(8):61. Review. PMID: 28664237
• Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS. Hum Pathol. 2017 May;63:149-156. PMID: 28315424
• Use of Main Renal Artery Clamping Predominates Over Minimal Clamping Techniques During Robotic Partial Nephrectomy for Complex Tumors. Lieberman L, Barod R, Dalela D, Diaz-Insua M, Abaza R, Adshead J, Ahlawat R, Challacombe B, Dasgupta P, Gandaglia G, Moon DA, Novara G, Porpiglia F, Mottrie A, Bhandari M, Rogers C. J Endourol. 2017 Feb;31(2):149-152. PMID: 27936928
• Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery.Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C. BJU Int. 2016 Aug;118(2):298-301. doi: 10.1111/bju.13408. Epub 2016 Feb 15. PMID: 27417163
• Use of the Satinsky clamp for hilar clamping during robotic partial nephrectomy: indications, technique, and multi-center outcomes. Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Kaouk J, Allaf M, Bhayani S, Stifelman M, Rogers C.J Robot Surg. 2016 Jun 21. [Epub ahead of print]. PMID: 27329237
• Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology. Lieberman L, Barod R, Tapper A, Kumar R, Rogers C.J Robot Surg. 2016 May 4. [Epub ahead of print]. PMID: 27146858
• Robotic partial nephrectomy for renal tumours in obese patients: Perioperative outcomes in a multi-institutional analysis. Abdullah N, Dalela D, Barod R, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C.Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E859-62. doi: 10.5489/cuaj.3197. Epub 2015 Dec 14.PMID: 26788235 Free PMC Article
• Robot-assisted hepatic mobilization and control of suprahepatic infradiaphragmatic inferior vena cava for level 3 vena caval thrombectomy: An IDEAL stage 0 study. Sood A, Jeong W, Barod R, Bahnson E, Kirura P, Abdollah F, Bhandari M, Bahnson R, Menon M.J Surg Oncol. 2015 Dec;112(7):741-5. doi: 10.1002/jso.23980. Epub 2015 Aug 11. Review. PMID: 26265131
• Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1 791 patients.Potretzke AM, Knight BA, Zargar H, Kaouk JH, Barod R, Rogers CG, Mass A, Stifelman MD, Johnson MH, Allaf ME, Sherburne Figenshau R, Bhayani SB.BJU Int. 2016 Jan;117(1):131-7. doi: 10.1111/bju.13249. Epub 2015 Sep 6.PMID: 26235802
• Endovascular Extraction of Caval Tumor Thrombus to Facilitate Minimally Invasive Cytoreductive Nephrectomy for Metastatic Kidney Cancer.Rogers C, Barod R, Schwartz S, Menon M.Eur Urol. 2015 Jul;68(1):167-8. doi: 10.1016/j.eururo.2015.03.039. Epub 2015 Apr 3. No abstract available.PMID: 25843640
• Primary prevention and vaccination for penile cancer.Shabbir M, Barod R, Hegarty PK, Minhas S.Ther Adv Urol. 2013 Jun;5(3):161-9. doi: 10.1177/1756287212465456.PMID: 23730331 Free PMC Article
• Epigenetic regulation of HIF-1? in renal cancer cells involves HIF-1?/2? binding to a reverse hypoxia-response element.Xu J, Wang B, Xu Y, Sun L, Tian W, Shukla D, Barod R, Grillari J, Grillari-Voglauer R, Maxwell PH, Esteban MA.Oncogene. 2012 Feb 23;31(8):1065-72. doi: 10.1038/onc.2011.305. Epub 2011 Aug 15.PMID: 21841824
• Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1?-mediated apoptosis.Khan MN, Bhattacharyya T, Andrikopoulos P, Esteban MA, Barod R, Connor T, Ashcroft M, Maxwell PH, Kiriakidis S.Br J Cancer. 2011 Mar 29;104(7):1151-9. doi: 10.1038/bjc.2011.73. Epub 2011 Mar 8. PMID: 21386837 Free PMC Article
• A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib.uthill M, Barod R, Pyle L, Cook T, Chew S, Gore M, Maxwell P, Eisen T.BMJ Case Rep. 2009;2009. pii: bcr08.2008.0732. Epub 2009 Feb 16.PMID: 21686655